This Changes Everything.
NGD has automated both the frontend sample preparation and the backend bioinformatic analysis to enable low-cost sequencing to transform microbiology diagnostics and infection control.
Next Gen Diagnostics delivers cutting-edge highly automated low cost sequencing and bioinformatics to detect, track, and prevent infectious disease spread, provide sequence based diagnostics and discover resistance mechanisms.
Our rapid, automated end-to-end sample preparation, whole-genome sequencing (WGS) and data analysis pipeline empowers healthcare, public health, and pharma leaders with real-time insights for better outbreak prevention, diagnostics and ultimately patient outcomes.
To find out how you can access the lowest-cost, highest-throughput, most-automated sequencing and bioinformatics click below.
Hospitals & Integrated Delivery Networks
Our systems empower your staff with the tools needed to rapidly identify infection sources and contain outbreaks with efficiency. We use low-cost automated WGS to detect transmission, reducing hospital stays and improving patient outcomes. Designed for hospitals and IDNs of all sizes, our solutions are cost-effective, easy to use, and require minimal training.
Public Health Labs
We provide powerful, cost-effective automated whole genome sequencing solutions for diverse applications, including outbreak preparedness, food and water safety, and antimicrobial resistance monitoring. Our comprehensive bacterial WGS service—covering extraction, library preparation, sequencing, and bioinformatics—offers Public Health Labs a superior alternative to other sequencing solutions at a lower cost.
Pharma
We partner with pharmaceutical companies to develop sequence-based diagnostics determining antibiotic resistance to drive innovation in drug development and clinical research. Our high-precision sequence-base diagnostics and advanced genomic technologies illuminate the mechanisms of drug resistance, support biomarker discovery, and accelerate antimicrobial resistance (AMR) research, optimising clinical trials. By empowering targeted inhibitor development, we help bring safer, more effective treatments to market faster.